Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Semin Nephrol
    May 2018
  1. JEGATHEESAN D, Cho Y, Johnson DW
    Clinical Studies of Interventions to Mitigate Cardiovascular Risk in Peritoneal Dialysis Patients.
    Semin Nephrol. 2018;38:277-290.
    >> Share

  2. HENAUT L, Chillon JM, Kamel S, Massy ZA, et al
    Updates on the Mechanisms and the Care of Cardiovascular Calcification in Chronic Kidney Disease.
    Semin Nephrol. 2018;38:233-250.
    >> Share

    March 2018
  3. LI DY, Tang WHW
    Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Semin Nephrol. 2018;38:193-205.
    >> Share

    November 2017
  4. ESTRELLA MM, Parekh RS
    The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease.
    Semin Nephrol. 2017;37:520-529.
    >> Share

    July 2017
  5. AHMED SB
    Menopause and Chronic Kidney Disease.
    Semin Nephrol. 2017;37:404-411.
    >> Share

  6. BRAMHAM K
    Pregnancy in Renal Transplant Recipients and Donors.
    Semin Nephrol. 2017;37:370-377.
    >> Share

  7. HLADUNEWICH MA
    Chronic Kidney Disease and Pregnancy.
    Semin Nephrol. 2017;37:337-346.
    >> Share

  8. AHMED SB, Vitek WS, Holley JL
    Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease.
    Semin Nephrol. 2017;37:327-336.
    >> Share

  9. DIAZ-GONZALEZ DE FERRIS ME, Alvarez-Elias AC, Ferris MT, Medeiros M, et al
    Female Adolescents with Chronic or End-Stage Kidney Disease and Strategies for their Care.
    Semin Nephrol. 2017;37:320-326.
    >> Share

    May 2017
  10. CHUENGSAMAN P, Kasemsup V
    PD First Policy: Thailand's Response to the Challenge of Meeting the Needs of Patients With End-Stage Renal Disease.
    Semin Nephrol. 2017;37:287-295.
    >> Share

  11. LUYCKX VA, Miljeteig I, Ejigu AM, Moosa MR, et al
    Ethical Challenges in the Provision of Dialysis in Resource-Constrained Environments.
    Semin Nephrol. 2017;37:273-286.
    >> Share

  12. CARRERO JJ, Hecking M, Ulasi I, Sola L, et al
    Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective.
    Semin Nephrol. 2017;37:296-308.
    >> Share

  13. DAVIDS MR, Caskey FJ, Young T, Balbir Singh GK, et al
    Strengthening Renal Registries and ESRD Research in Africa.
    Semin Nephrol. 2017;37:211-223.
    >> Share

    March 2017
  14. RIVARA MB, Mehrotra R
    Timing of Dialysis Initiation: What Has Changed Since IDEAL?
    Semin Nephrol. 2017;37:181-193.
    >> Share

  15. MOIST LM, Lok CE
    Incident Dialysis Access in Patients With End-Stage Kidney Disease: What Needs to Be Improved.
    Semin Nephrol. 2017;37:151-158.
    >> Share

  16. BANSAL N
    Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.
    Semin Nephrol. 2017;37:120-131.
    >> Share

  17. FOLEY RN
    Epidemiology and Risk Factors for Early Mortality After Dialysis Initiation.
    Semin Nephrol. 2017;37:114-119.
    >> Share

  18. KURELLA TAMURA M
    Optimizing the Transition to End-Stage Renal Disease.
    Semin Nephrol. 2017;37:113.
    >> Share

  19. WAGNER LA, Fink JC
    Ensuring Patient Safety During the Transition to ESRD.
    Semin Nephrol. 2017;37:194-208.
    >> Share

  20. SCHMIDT RJ
    Advance Care Planning for Patients Approaching End-Stage Kidney Disease.
    Semin Nephrol. 2017;37:173-180.
    >> Share

  21. SHESHADRI A, Johansen KL
    Prehabilitation for the Frail Patient Approaching ESRD.
    Semin Nephrol. 2017;37:159-172.
    >> Share

  22. SUMIDA K, Kovesdy CP
    Disease Trajectories Before ESRD: Implications for Clinical Management.
    Semin Nephrol. 2017;37:132-143.
    >> Share

    January 2017
  23. CHO Y, Struijk DG
    Peritoneal Dialysis-Related Peritonitis: Atypical and Resistant Organisms.
    Semin Nephrol. 2017;37:66-76.
    >> Share

  24. LI PK, Ng JK, Mcintyre CW
    Inflammation and Peritoneal Dialysis.
    Semin Nephrol. 2017;37:54-65.
    >> Share

  25. KIM YL, Biesen WV
    Fluid Overload in Peritoneal Dialysis Patients.
    Semin Nephrol. 2017;37:43-53.
    >> Share

  26. SZETO CC, Johnson DW
    Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.
    Semin Nephrol. 2017;37:30-42.
    >> Share

  27. CRABTREE JH, Chow KM
    Peritoneal Dialysis Catheter Insertion.
    Semin Nephrol. 2017;37:17-29.
    >> Share

  28. YU X, Mehrotra R, Yang X
    Components of A Successful Peritoneal Dialysis Program.
    Semin Nephrol. 2017;37:10-16.
    >> Share

  29. ALSTON H, Fan S, Nakayama M
    Encapsulating Peritoneal Sclerosis.
    Semin Nephrol. 2017;37:93-102.
    >> Share

  30. BAJO MA, Del Peso G, Teitelbaum I
    Peritoneal Membrane Preservation.
    Semin Nephrol. 2017;37:77-92.
    >> Share

  31. LI PK, Kwong VW
    Current Challenges and Opportunities in PD.
    Semin Nephrol. 2017;37:2-9.
    >> Share

    November 2016
  32. BREYER MD, Susztak K
    Developing Treatments for Chronic Kidney Disease in the 21st Century.
    Semin Nephrol. 2016;36:436-447.
    >> Share

    September 2016
  33. ABAD CL, Razonable RR
    alpha Herpes Virus Infections Among Renal Transplant Recipients.
    Semin Nephrol. 2016;36:344-350.
    >> Share

    July 2016
  34. WANG V, Vilme H, Maciejewski ML, Boulware LE, et al
    The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
    Semin Nephrol. 2016;36:319-30.
    >> Share

  35. PENA-POLANCO JE, Fried LF
    Established and Emerging Strategies in the Treatment of Chronic Kidney Disease.
    Semin Nephrol. 2016;36:331-42.
    >> Share

  36. HSU RK, Hsu CY
    The Role of Acute Kidney Injury in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:283-92.
    >> Share

  37. COLLISTER D, Ferguson T, Komenda P, Tangri N, et al
    The Patterns, Risk Factors, and Prediction of Progression in Chronic Kidney Disease: A Narrative Review.
    Semin Nephrol. 2016;36:273-82.
    >> Share

  38. PANWAR B, Gutierrez OM
    Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:252-61.
    >> Share

    March 2016
  39. SHAH HH, Hazzan AD, Fishbane S
    Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
    Semin Nephrol. 2016;36:124-9.
    >> Share

  40. PANDEY R, Daloul R, Coyne DW
    Iron Treatment Strategies in Dialysis-Dependent CKD.
    Semin Nephrol. 2016;36:105-11.
    >> Share

  41. BLOCK GA
    Ferric Citrate in Patients With Chronic Kidney Disease.
    Semin Nephrol. 2016;36:130-5.
    >> Share

  42. FISHBANE S
    Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:119-23.
    >> Share

  43. BAHRAINWALA J, Berns JS
    Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:94-8.
    >> Share

  44. GANZ T, Nemeth E
    Iron Balance and the Role of Hepcidin in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:87-93.
    >> Share

  45. FISHBANE S
    Introduction: Iron Management in Chronic Kidney Disease.
    Semin Nephrol. 2016;36:85-6.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016